Systemic Therapy Is Associated with Improved Oncologic Outcomes in Resectable Stage II/III Intrahepatic Cholangiocarcinoma: An Examination of the National Cancer Database over the Past Decade

SIMPLE SUMMARY: Intrahepatic cholangiocarcinoma (ICC) is a primary liver cancer that currently has limited treatment options and an overall poor prognosis. Evidence-based guidelines for the management of resectable ICC are lacking. We investigated three treatment strategies for resectable ICC using...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcus, Rebecca, Christopher, Wade, Keller, Jennifer, Nassoiy, Sean, Chang, Shu-Ching, Goldfarb, Melanie, Wolf, Ronald, Jutric, Zeljka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454548/
https://www.ncbi.nlm.nih.gov/pubmed/36077855
http://dx.doi.org/10.3390/cancers14174320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454548/
https://www.ncbi.nlm.nih.gov/pubmed/36077855
http://dx.doi.org/10.3390/cancers14174320

Ejemplares similares